These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16626942)

  • 21. Scotopic sensitivity in coyotes (Canis latrans).
    Horn SW; Lehner PN
    J Comp Physiol Psychol; 1975 Nov; 89(9):1070-6. PubMed ID: 1202101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of mid-term stability of night vision tests.
    Levy Y; Glovinsky Y
    Aviat Space Environ Med; 1997 Jul; 68(7):565-8. PubMed ID: 9215460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
    Kelemen O; Kiss I; Benedek G; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with ocular hypertension have abnormal point scotopic thresholds in the superior hemifield.
    Stirling RJ; Pawson P; Brimlow GM; Vernon SA
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1608-17. PubMed ID: 8675404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global visual scanning abnormalities in schizophrenia and bipolar disorder.
    Bestelmeyer PE; Tatler BW; Phillips LH; Fraser G; Benson PJ; St Clair D
    Schizophr Res; 2006 Oct; 87(1-3):212-22. PubMed ID: 16860975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia.
    Cimmer C; Szendi I; Csifcsák G; Szekeres G; Ambrus Kovács Z; Somogyi I; Benedek G; Janka Z; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1225-30. PubMed ID: 16644085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early stage vision in schizophrenia and schizotypal personality disorder.
    O'Donnell BF; Bismark A; Hetrick WP; Bodkins M; Vohs JL; Shekhar A
    Schizophr Res; 2006 Sep; 86(1-3):89-98. PubMed ID: 16829048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual perception in medicated schizophrenic patients.
    Schwartz B; Winstead DK
    Am J Psychiatry; 1997 Apr; 154(4):585-7. PubMed ID: 9090363
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychometrically matched visual-processing tasks in schizophrenia spectrum disorders.
    Brenner CA; Wilt MA; Lysaker PH; Koyfman A; O'Donnell BF
    J Abnorm Psychol; 2003 Feb; 112(1):28-37. PubMed ID: 12653411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of early bottom-up and top-down deficits during visual attention in schizophrenia.
    Neuhaus AH; Karl C; Hahn E; Trempler NR; Opgen-Rhein C; Urbanek C; Hahn C; Ta TM; Dettling M
    Clin Neurophysiol; 2011 Jan; 122(1):90-8. PubMed ID: 20609622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of scotopic sensitivity.
    Fulton AB; Hansen RM
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1588-96. PubMed ID: 10798680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a yellow intraocular lens on scotopic vision, glare disability, and blue color perception.
    Muftuoglu O; Karel F; Duman R
    J Cataract Refract Surg; 2007 Apr; 33(4):658-66. PubMed ID: 17397740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of briefly flashed sine-gratings in dark-adapted vision.
    Hofmann MI; Barnes CS; Hallett PE
    Vision Res; 1990; 30(10):1453-66. PubMed ID: 2247955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aging and scotopic sensitivity.
    Jackson GR; Owsley C; Cordle EP; Finley CD
    Vision Res; 1998 Nov; 38(22):3655-62. PubMed ID: 9893796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency-doubling illusion under scotopic illumination and in peripheral vision.
    Vallam K; Pataridis I; Metha AB
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3413-8. PubMed ID: 17591916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits.
    Rassovsky Y; Green MF; Nuechterlein KH; Breitmeyer B; Mintz J
    Schizophr Res; 2004 Dec; 71(2-3):485-92. PubMed ID: 15474919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scotopic thresholds and plasma retinol in cystic fibrosis.
    Fulton AB; Hansen RM; Underwood BA; Shwachman H; Barg DC
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):364-70. PubMed ID: 7107162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human scotopic dark adaptation: Comparison of recoveries of psychophysical threshold and ERG b-wave sensitivity.
    Ruseckaite R; Lamb TD; Pianta MJ; Cameron AM
    J Vis; 2011 Jul; 11(8):. PubMed ID: 21733908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical locus of coherent motion deficits in deaf poor readers.
    Samar VJ; Parasnis I
    Brain Cogn; 2007 Apr; 63(3):226-39. PubMed ID: 17046130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesopic luminance assessed with minimum motion photometry.
    Raphael S; MacLeod DI
    J Vis; 2011 Aug; 11(9):. PubMed ID: 21868482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.